Coronado Releases Interim Data; Says Final Results of Study Expected Mid 2014

Coronado Biosciences, Inc. (Nasdaq: CNDO ), a biopharmaceutical company developing novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Eric Hollander, Clinical Professor of Psychiatry and Behavioral Sciences at Albert Einstein College of Medicine of Yeshiva University and Director of the Autism and Obsessive Compulsive Spectrum Program at